BackOyster Point Pharma Overview

Oyster Point Pharma Current Assets

Track Oyster Point Pharma's current assets ($98M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$97.71M
↓ 48.49% YoYΔ $-91.98M vs prior year quarter

Peer trimmed avg / median

Loading

Oyster Point Pharma Current Assets History

Loading

Oyster Point Pharma vs. peers: Current Assets Comparison

Loading

Oyster Point Pharma Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Oyster Point Pharma (OYST) FAQ

As of the most recent data (September 2022), OYST shows a current assets of $98M. That compares with $190M in the prior-year period — down 48.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OYST's current assets is now $98M (was $190M) — a 48.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Oyster Point Pharma is outperforming or lagging.

Tracking OYST's current assets over time shows whether Oyster Point Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $98M That compares with $190M in the prior-year period — down 48.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Oyster Point Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $98M) with ownership activity and broader fundamentals.

Oyster Point Pharma's current assets is $98M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.